HIV and Antiretrovirals
Speaker/Faculty
Dr. Sharon Weissman
-
Review recent information on the coadministration of tenofovir disoproxil fumarate with other agents commonly used by HIV-infected patients.
-
Outline recent pharmacokinetic data on double-boosted protease inhibitor (PI) regimens.
-
Describe pharmacokinetic considerations affecting agents used in the treatment of HIV-infected patients with hepatitis coinfection or metabolic dysfunction.
Phone:
(617) 262-5657